161. 家族性良性慢性天疱瘡 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 6 / 薬物数 : 6 - (DrugBank : 3) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 29
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Botulism toxin treatment
University Hospital, Toulouse
2015 Phase 1 NCT02782702 -
Celecoxib
Juntendo university gradurate school of medicine
2013 - JPRN-UMIN000010191 Japan
Doxycycline
Gangnam Severance Hospital
2020 - NCT05007223 Korea, Republic of
Guselkumab
Yale University
2025 Phase 2 NCT06651489 United States
LX3305 250 MG capsule
Dermecular Therapeutics, Inc.
2018 Phase 1;Phase 2 EUCTR2018-000373-80-FR France
Scenesse
ISTITUTI FISIOTERAPICI OSPITALIERI
2013 Phase 2 EUCTR2013-004562-33-IT Italy
University Hospital, Toulouse
2015 Phase 1 NCT02782702 -
Celecoxib
Juntendo university gradurate school of medicine
2013 - JPRN-UMIN000010191 Japan
Doxycycline
Gangnam Severance Hospital
2020 - NCT05007223 Korea, Republic of
Guselkumab
Yale University
2025 Phase 2 NCT06651489 United States
LX3305 250 MG capsule
Dermecular Therapeutics, Inc.
2018 Phase 1;Phase 2 EUCTR2018-000373-80-FR France
Scenesse
ISTITUTI FISIOTERAPICI OSPITALIERI
2013 Phase 2 EUCTR2013-004562-33-IT Italy